Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.700
-0.150 (-8.11%)
At close: Aug 17, 2026, 4:00 PM EDT
1.700
0.00 (-0.01%)
After-hours: Aug 17, 2026, 7:40 PM EDT

Health Catalyst Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Health Catalyst stock has a consensus rating of "Buy" and an average price target of $1.83. The average 1-year stock price forecast is 7.65% higher than the current stock price, while the lowest is $1.50 (-11.76%) and the highest is $2.00 (+17.65%).

Price Target: $1.83 (+7.65%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$1.50$1.83$2.00$2.00
Change-11.76%+7.65%+17.65%+17.65%

Analyst Ratings

The average analyst rating for Health Catalyst stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy222222
Buy000000
Hold776554
Sell000000
Strong Sell000000
Total998776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Hold
Reiterates
$1.75$1.5
HoldReiterates$1.75$1.5-11.76%Aug 13, 2026
Citi
Citi
Hold
Reiterates
$2.5$2
HoldReiterates$2.5$2+17.65%Aug 10, 2026
Stifel Nicolaus
Stifel Nicolaus
Hold
Maintains
$2
HoldMaintains$2+17.65%Aug 7, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aAug 7, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$2$3
BuyMaintains$2$3+76.47%Jul 21, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
247.37M
from 311.14M
Decreased by -20.49%
Revenue Next Year
206.13M
from 247.37M
Decreased by -16.67%
EPS This Year
-0.05
from 0.18
EPS Next Year
0.04
from -0.05
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
241.93M276.24M295.94M306.58M311.14M247.37M
Revenue Growth
28.11%14.18%7.13%3.60%1.49%-20.49%
Gross Profit
117.76M135.56M134.83M141.79M154.63M120.72M
Gross Margin
48.68%49.07%45.56%46.25%49.70%48.80%
Operating Income
-113.92M-126.33M-92.88M-57.10M-43.17M-161.38M
Net Income
-153.21M-137.40M-118.15M-69.50M-177.97M-178.75M
EPS
----0.18-0.05
Free Cash Flow
24.68M13.04M17.88M29.45M10.73M48.00M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High247.6M
Avg247.4M
Low247.2M

Revenue Growth

Revenue Growth202620272028
High
-20.4%
Avg
-20.5%
Low
-20.5%

EPS Forecast

EPS202620272028
High-
Avg-0.05
Low-0.09

EPS Growth

EPS Growth202620272028
High
-100.0%
Avg-
Low-